Journal of Biological Chemistry · 2000 · 38 citations · 36 references
Life SciencesBiochemistryMolecular BiologyApoptosisEnzymologyMolecular Cell BiologyApoptosis RegulationApoptotic SignalingCell DeathApoptotic ResponseBasic Leucine Zipper DomainsDna Damage-induced Cell DeathDouble-strand Break-induced ApoptosisParp InhibitionPoly(adp-ribose) Polymerase ActivityPoly(adp-ribose) Polymerase InhibitionProtein-protein Interactions In Apoptosis
The biochemical role of the C-terminal fragment of poly(ADP-ribose) polymerase (PARP) was investigated in HeLa cells undergoing UV-mediated apoptosis. During the course of apoptosis, the C-terminal cleavage product of PARP interacted with intact PARP and down-regulated PARP activity by blocking the homodimerization of PARP. The basic leucine zipper motif in the auto-modification domain of the C-terminal fragment of PARP represented the site of association, and Leu405 was critical to the ability of the basic leucine zipper motif to associate with intact PARP. The expression of the C-terminal fragment of PARP stimulated UV-mediated apoptosis. These results suggest that the C-terminal cleavage product of PARP produced during apoptosis blocks the homodimerization of PARP and inhibits the cellular PARP activity. The inhibition of the cellular PARP activity might prevent cellular NAD+ depletion and stimulate apoptosis by maintaining the basal cellular energy level required for the completion of apoptosis. The biochemical role of the C-terminal fragment of poly(ADP-ribose) polymerase (PARP) was investigated in HeLa cells undergoing UV-mediated apoptosis. During the course of apoptosis, the C-terminal cleavage product of PARP interacted with intact PARP and down-regulated PARP activity by blocking the homodimerization of PARP. The basic leucine zipper motif in the auto-modification domain of the C-terminal fragment of PARP represented the site of association, and Leu405 was critical to the ability of the basic leucine zipper motif to associate with intact PARP. The expression of the C-terminal fragment of PARP stimulated UV-mediated apoptosis. These results suggest that the C-terminal cleavage product of PARP produced during apoptosis blocks the homodimerization of PARP and inhibits the cellular PARP activity. The inhibition of the cellular PARP activity might prevent cellular NAD+ depletion and stimulate apoptosis by maintaining the basal cellular energy level required for the completion of apoptosis. poly(ADP-ribose) polymerase glutathione S-transferase green fluorescence protein basic leucine zipper 7-amino-4-methylcoumarin fluorescein isothiocyanate hemaglutinin nuclear localization signal polyacrylamide gel electrophoresis G protein-coupled receptor excitation Emission Activation of caspases has been generally accepted as a common cellular event that occurs in cells undergoing apoptosis (1.Cryns V. Yuan J. Genes Dev. 1998; 12: 1551-1570Crossref PubMed Scopus (1161) Google Scholar). Numerous cellular proteins are cleaved by caspases during the course of apoptosis. However, the biochemical consequence of proteolytic cleavage of the substrate proteins by caspases during the course of apoptosis has been poorly understood. PARP1 has been known to be cleaved by caspases during apoptosis (2.Lazebnik Y.A. Kaufmann S.H. Desnoyers S. Poirier G.G. Earnshaw W.C. Nature. 1994; 371: 346-347Crossref PubMed Scopus (2346) Google Scholar). The cleavage of PARP yields a 25-kDa N-terminal fragment containing two zinc-fingers and an 89-kDa C-terminal fragment containing the auto-modification domain and the NAD+ binding domain (3.Kaufmann S.H. Desnoyers S. Ottaviano Y. Davidson N.E. Poirier G.G. Cancer Res. 1993; 53: 3976-3985PubMed Google Scholar). The two zinc-finger motifs in the N-terminal DNA-binding domain bind to DNA at the sites of single- or double-stranded breaks, resulting in the catalytic activation of PARP. The DNA-bound, activated PARP utilizes NAD+ to synthesize poly(ADP-ribose) on various nuclear proteins, such as DNA polymerase α (4.Yoshihara S. Simbulan C.M.G. Mol. Cell. Biochem. 1994; 138: 39-44Crossref PubMed Scopus (18) Google Scholar) and β (5.Ohashi Y. Itaya A. Tanaka Y. Yoshihara K. Kamiya T. Matsukage A. Biochem. Biophys. Res. Commun. 1986; 140: 666-673Crossref PubMed Scopus (23) Google Scholar), topoisomerase I (6.Ferro A.M. Olivera B.M. J. Biol. Chem. 1984; 259: 547-554Abstract Full Text PDF PubMed Google Scholar) and II (7.Darby M.K. Schmitt B. Jongstra-Bilen J. Vosberg H.P. EMBO J. 1985; 4: 2129-2134Crossref PubMed Scopus (114) Google Scholar), histones (8.Huletsky A. Niedergang C. Frechette A. Aubin R. Gaudreau A Poirier G.G. Eur. J. Biochem. 1985; 146: 277-285Crossref PubMed Scopus (51) Google Scholar), p53 (9.Wesierska-Gadek J. Schimid G. Cerni C. Biochem. Biophys. Res. Commun. 1996; 224: 96-102Crossref PubMed Scopus (81) Google Scholar), DNA-dependent protein kinase (10.Ruscetti T. Lehnert B.E. Halbrook J. Le Trong H. Hoekstra M.F. Chen D.J. Peterson S.R. J. Biol. Chem. 1998; 273: 14461-14467Abstract Full Text Full Text PDF PubMed Scopus (211) Google Scholar), and PARP itself (11.Lindahl T. Satoh M.S. Poirier G.G. Klungland A. Trends Biol. Sci. 1995; 20: 405-411Abstract Full Text PDF PubMed Scopus (573) Google Scholar). Many studies have described PARP as a positive regulator of apoptosis. The overexpression of PARP in the transfected cells was known to stimulate apoptosis (12.Van Gool L. Meyer R. Tobiasch E. Cziepluch C. Jauniaux J.C. Mincheva A. Lichter P. Poirier G.G. Burkle A. Kupper J.H. Eur. J. Biochem. 1997; 244: 15-20Crossref PubMed Scopus (52) Google Scholar). The pro-apoptotic role of PARP activation was further supported by the finding that a specific chemical inhibitor of PARP, 3-aminobenzamide, suppresses apoptosis (13.Nosseri C. Coppola S. Ghibelli L. Exp. Cell. Res. 1994; 212: 367-373Crossref PubMed Scopus (174) Google Scholar). However, the controversial roles of PARP during apoptosis have been argued in the studies using PARP-deficient mice. Wang et al. (14.Wang Z.Q. Stingl L. Morrison C. Jantsch M. Los M. Schulze-Osthoff K. Wagner E.F. Genes Dev. 1997; 11: 2347-2358Crossref PubMed Scopus (515) Google Scholar) proposed a dispensable role of PARP in apoptosis by showing a normal level of apoptosis in PARP-deficient mouse cells treated with various apoptosis inducers. An indispensible role of PARP on apoptosis was presented by Simbulan-Rosenthal et al. (15.Simbulan-Rosenthal C.M. Rosenthal D.S. Iyer S. Boulares A.H. Smulson M.E. J. Biol. Chem. 1998; 273: 13703-13712Abstract Full Text Full Text PDF PubMed Scopus (256) Google Scholar), who reported an early burst of poly(ADP-ribosyl)ation of nuclear proteins during Fas-mediated apoptosis in PARP+/+ cells, whereas no induction of apoptosis was shown in PARP−/− cells by Fas stimulation. The importance of PARP cleavage in apoptosis has recently been recognized. For example, it has been suggested that the activity of PARP is stimulated by DNA breaks during the early course of apoptosis, but proteolytic cleavage decreases PARP activity in the late course of apoptosis (16.Rosenthal D.S. Ding R. Simbulan-Rosenthal C.M. Vaillancourt J.P. Nicholson D.W. Smulson M. Exp. Cell. Res. 1997; 232: 313-321Crossref PubMed Scopus (78) Google Scholar). Oliver et al. (17.Oliver F.J. de la Rubia G. Rolli V. Ruiz-Ruiz M.C. de Murcia G. Menissier-de Murcia J. J. Biol. Chem. 1998; 273: 33533-33539Abstract Full Text Full Text PDF PubMed Scopus (666) Google Scholar) observed a delayed apoptosis in PARP−/− cells expressing an uncleavable mutant of PARP. They suggested that PARP cleavage might be a sign that cells should undergo apoptosis because cells were unable to repair the cellular injury triggered by the apoptosis inducers. More recently, the importance of PARP cleavage during apoptosis was emphasized by the finding that the extensive poly(ADP-ribosyl)ation of p53 early during apoptosis decreases, as activated caspase-3 cleaves PARP and the expression of p53-responsive pro-apoptotic genes, bax andFas, is elevated during the late course of apoptosis (18.Simbulan-Rosenthal C.M. Rosenthal D.S. Luo R. Smulson M.E. Cancer Res. 1999; 59: 2190-2194PubMed Google Scholar). However, the biological relevance of PARP cleavage during apoptosis and the cellular function of the cleavage products have not been yet clarified. Recent studies have proposed that an adequate level of intracellular ATP is required for the completion of apoptosis (19.Leist M. Single B. Castoldi A.F. Kuhnle S. Nicotera P. J. Exp. Med. 1997; 185: 1481-1486Crossref PubMed Scopus (1642) Google Scholar, 20.Eguchi Y. Srinivasan A. Tomaselli K.J. Shimizu S. Tsujimoto Y. Cancer Res. 1999; 59: 2174-2181PubMed Google Scholar). Because the intracellular ATP level is directly affected by the catalytic activity of PARP, apoptosis, an energy-requiring process, may well be influenced by PARP activity. The N-terminal fragment of PARP containing the DNA-binding domain preferentially binds to DNA breaks and prevents the activation of PARP, whose activity is stimulated by DNA binding (21.Rhun Y.L. Kirkland J.B. Shah G.M. Biochem. Biophys. Res. Commun. 1998; 245: 1-10Crossref PubMed Scopus (185) Google Scholar). The pro-apoptotic role of the N-terminal fragment of PARP on apoptosis has been strongly supported by a recent finding that the N-terminal fragment of PARP irreversibly binds to DNA ends produced during apoptosis (22.Smulson M.E. Pang D. Jung M. Dimtchev A. Chasovskikh S. Spoonde A. Simbulan-Rosenthal C. Rosenthal D. Yakovlev A. Dritschilo A. Cancer Res. 1998; 58: 3495-3498PubMed Google Scholar). However, the role of the C-terminal fragment of PARP on apoptosis has not been delineated. In the present study, we propose a putative role for the C-terminal cleavage product of PARP on apoptosis based on the following findings: (a) the C-terminal fragment of PARP interacts with intact PARP through an association between the auto-modification domains and (b) the C-terminal fragment suppresses its catalytic activity by blocking homodimerization of PARP. We have found that the disruption of homodimerization of PARP by the cleaved C-terminal fragment stimulates apoptosis in UV-treated HeLa cells. Radioactive chemicals, including [adenylated-32P]NAD+ (∼1,000 Ci/mmol) and [35S]methionine (1,000 Ci/mmol) were obtained from Amersham Pharmacia Biotech. Anti-PARP monoclonal antibody against the C-terminal domain of PARP (MCA 1522) was purchased from Serotech. Monoclonal antibody against glutathione S-transferase (GST) was supplied by Sigma. Anti-green fluorescent protein (GFP) IgG was from CLONTECH. Monoclonal antibody against hemaglutinin (HA) was purchased from Roche Molecular Biochemicals. Annexin V-FITC was purchased from Pharmingen. The cDNA encoding full-length human PARP and truncated PARP fragments were cloned in-frame to pEGFP-C1 (CLONTECH) or pEBG vector to produce GFP or GST fusion products, respectively. For the active transport of GFP-N214 and GFP-M in the nuclei of HeLa cells, the PKKKRK sequence of the nuclear localization signal (NLS) in SV40 large T-antigen (23.Kalderon D.B. Roberts B.L. Richardson W.D. Smith A.E. Cell. 1984; 39: 499-509Abstract Full Text PDF PubMed Scopus (1864) Google Scholar) was inserted between GFP and the N termini of PARP fragments by polymerase chain reaction using oligomers of 5′-GGAATTCAAGCTTCGCCAAAGAAAAAAGCGAAAGTCGACGCGC-3′ and 5′-GCGCGTCGACTTTCGCTTTTTTCTTTGGCGAAGCTTGAATTCC-3′. N214-NLS and M-NLS were then prepared by polymerase chain reaction to construct pEBG-N214 and pEBG-M, respectively. The vector constructs encoding PARP fragments were transfected into cells by employing LipofectAMINE reagent (Life Technologies, Inc.). HeLa cells (107) were transiently co-transfected with 2 μg of pSRα-HA-PARP and 2 μg of pEBG, pEBG-N214, pEBG-C215, pEBG-M, pEBG-PARPΔM, or pEBG-MΔbZip. After incubation for 36 h, cells were irradiated with 50 J/m2 UV and incubated for 6 h. The cellular PARP activity was measured by the method of Grube et al. (24.Grube K. Kupper J. Burkle A. Anal. Biochem. 1991; 193: 236-239Crossref PubMed Scopus (34) Google Scholar) with some modifications. Permeabilized cells were incubated with 10 μCi/ml of [32P]NAD+ for 30 min at 30 °C. Cells were lysed by adding Nonidet P-40 (final concentration, 1%), and HA-tagged PARP (HA-PARP) was immunoprecipitated using monoclonal antibody against HA. The catalytic activity of PARP was assessed by examining auto-poly(ADP-ribosyl)ation of HA-PARP in 10% SDS-PAGE followed by autoradiography. PARP derivatives were cloned in pGEX-5X-3, and GST-fused PARP fragments were produced inEscherichia coli BL21(DE3) cells. Purified GST fusion products (1 μg) were transferred to 200 μl of an assay buffer consisting of 20 mm Tris (pH 7.4), 100 mm NaCl, 2 mm EDTA, 0.1% Nonidet P-40, 2 mmdithiothreitol, 0.05% bovine serum albumin, and 5% glycerol (25.Takayama S. Sato T. Krajewski S. Kochel K. Irie S. Millan J.A. Reed J.C. Cell. 1995; 80: 279-284Abstract Full Text PDF PubMed Scopus (797) Google Scholar). The35S-labeled PARP was prepared by in vitrotranscription/translation procedures using TNT linked kit (Promega).In vitro translated 35S-labeled PARP was treated with 1 unit of DNase I for 30 min prior to the incubation with GST fusion products at 4 °C for 1 h. The GST fusion products were recovered in glutathione-Sepharose 4B beads (Amersham Pharmacia Biotech) and washed three times with phosphate-buffered saline (pH 7.4). The 35S-labeled PARP bound to GST fusion products was analyzed by 10% SDS-PAGE and subsequent autoradiography. HeLa cells (107) were transfected with 2 μg of pEBG, pEBG-N214, pEBG-C215, pEBG-M, pEBG-PARPΔM or pEBG-MΔbZip and incubated for 36 h. Cells were lysed in a lysis buffer containing 100 mm Tris (pH 7.4), 150 mm NaCl and 1% Nonidet P-40 for 30 min on ice. After centrifugation of cell lysate at 10,000 × g for 5 min, the resulting supernatant was incubated with glutathione-Sepharose 4B resin for 1 h at 4 °C. The resin was washed three times with phosphate-buffered saline and the bound proteins were analyzed by Western blotting using monoclonal antibody against the C terminus of PARP following by 10% SDS-PAGE. Cells were lysed in a lysis buffer containing 20 mm HEPES (pH 7.4), 100 mm NaCl, 0.5% Nonidet P-40, 10 mm dithiothreitol, 1 mmphenylmethylsulfonyl fluoride, and 1 mg/ml leupeptin. Caspase activity was measured using a fluorogenic peptide substrate, zVAD-AMC (Bachem). Cell lysate proteins (10 μg) were incubated with 20 μmof zVAD-AMC for 2 h at 30 °C, and caspase activity was monitored fluorometrically in a fluorescence spectrophotometer (excitation, 366 nm; emission, 465 nm). HeLa cells (105) expressing GFP fusion products were irradiated with 100J/m2UV, resuspended in 100 μl of an incubation buffer containing 10 mm HEPES (pH 7.4), 140 mm NaCl, 2.5 mm CaCl2, and 5% Annexin-V-FITC solution (Pharmingen) and incubated at room temperature for 15 min in the dark. Green fluorescent and annexin-V positive cells were analyzed by fluorescence activated cell sorter (FACScalibur System; Becton-Dickinson) (26.Koopman G. Reutelingsperger C.P.M. Kuijten G.A.M. Keehnen R.M.J. Pals S.T. van Oers M.H.J. Blood. 1994; 84: 1415-1420Crossref PubMed Google Scholar). The apoptotic morphology of cells were evaluated by fluorescence microscopic observation (excitation, 490 nm; emission, 510 nm). After the induction of apoptosis, cells were fixed with 4% for 30 min, and apoptotic cells expressing GFP with nuclei were the cells with (1 for 10 PARP is a catalytic and the of PARP is known to stimulate its catalytic activity A. E. Biochem. J. PubMed Scopus Google Scholar, H. R. J. Biol. Chem. 1993; Full Text PDF PubMed Google Scholar). PARP domains in the were as shown in GST-fused PARP fragments were incubated with prepared by in vitrotranscription/translation and bound to GST-fused PARP fragments was by 10% SDS-PAGE GST the of of PARP by the DNA that the DNA-binding domains of PARP DNA vitro procedures was with DNase I GST The between intact PARP and the N-terminal fragments that the DNA-binding domain DNase I that the association was by In the C-terminal fragments of PARP the association with DNase I 1 shown in 1 that the auto-modification domain of PARP is the site of A motif known to in PubMed Scopus Google Scholar, R. 245: PubMed Scopus Google Scholar) has been in the auto-modification domain of PARP. we the motif in the auto-modification domain a for the in C strongly suggest that the motif in the auto-modification domain of PARP the site of the The association of the cellular PARP was in GST-fused PARP fragments were in HeLa cells, and the association of GST fusion products with the cellular PARP was monitored by using monoclonal antibody 2 that the motif in the auto-modification domain interacts with the cellular PARP. A putative role of the C-terminal fragment of PARP on the was investigated in cells HA-tagged PARP (HA-PARP) with GST-fused PARP The association of the cellular PARP with HA-PARP was by the PARP fragments containing the auto-modification domain and However, a PARP fragment that the auto-modification domain or an auto-modification domain that the to the of PARP in the transfected cells 2 The motif in the auto-modification domain of PARP leucine K. S. K. Y. M. T. M. Sci. S. A. 1993; PubMed Scopus Google Scholar). the function of the leucine was evaluated in an in the leucine in the motif were and the association of intact PARP with the auto-modification domain was The leucine in the motif were for the association, and of critical The auto-modification domain in Leu405 was to to with 35S-labeled PARP prepared by in vitro However, the association between the auto-modification domain and intact PARP was not by the of leucine to that is in the The role of the C-terminal fragment of PARP on the cellular PARP activity was in co-transfected HeLa cells expressing HA-PARP and GST-fused PARP Cells were irradiated with 50 J/m2 UV and incubated for 30 min in a containing HA-PARP was then by and the cellular PARP was assessed by the of from NAD+ to The expression of the C-terminal fragments that the motif and the cellular PARP activity. The auto-modification domain that the motif to with the cellular PARP activity. that the cellular PARP activity was by the expression of PARP fragments containing N-terminal fragment and a known inhibitor of PARP M. Burkle A. Murcia M. Kupper J.H. de Murcia G. EMBO J. 1993; 12: PubMed Scopus Google Scholar, V. D. C. B. D. de Murcia G. de Murcia Sci. S. A. 1995; PubMed Scopus Google Scholar). These results that the C-terminal fragment of PARP as well as N-terminal fragment is the inhibitor of the PARP in HeLa cells followed by UV were evaluated by the activation of caspase and annexin-V binding to at the of apoptotic HeLa cells. PARP cleavage products not with the caspase activation in cells undergoing apoptosis The expression of the N-terminal or C-terminal fragment containing the elevated level of UV-mediated apoptosis, as assessed by the of annexin-V binding at the cell 5 In cells expressing the N-terminal or C-terminal fragment containing the motif to apoptosis, such as nuclei 5 PARP cleavage has been as a biochemical of apoptosis, the relevance and consequence of PARP cleavage during apoptosis have not been clarified. A recent by Oliver et al. (17.Oliver F.J. de la Rubia G. Rolli V. Ruiz-Ruiz M.C. de Murcia G. Menissier-de Murcia J. J. Biol. Chem. 1998; 273: 33533-33539Abstract Full Text Full Text PDF PubMed Scopus (666) Google Scholar) that apoptosis was delayed in cells expressing an uncleavable PARP and Wang Wang Mol. Cell. Biol. 1999; PubMed Scopus Google Scholar) reported that the of PARP cleavage by the depletion of cellular energy in cells treated with various apoptotic inducers. These results suggested that the of PARP by the proteolytic cleavage is a for the completion of apoptosis. In the present study, we to the biological of the proteolytic cleavage of PARP during the course of apoptosis. We found that apoptosis the function of PARP, whose catalytic activity is by its proteolytic cleavage The N-terminal fragment of PARP containing the DNA-binding domain preferentially binds to DNA breaks and prevents the activation of PARP M. Burkle A. Murcia M. Kupper J.H. de Murcia G. EMBO J. 1993; 12: PubMed Scopus Google Scholar, V. D. C. B. D. de Murcia G. de Murcia Sci. S. A. 1995; PubMed Scopus Google Scholar). has been that the N-terminal fragment of PARP irreversibly binds to DNA ends produced during apoptosis (22.Smulson M.E. Pang D. Jung M. Dimtchev A. Chasovskikh S. Spoonde A. Simbulan-Rosenthal C. Rosenthal D. Yakovlev A. Dritschilo A. Cancer Res. 1998; 58: 3495-3498PubMed Google Scholar). The binding of the N-terminal fragment of PARP to DNA breaks has generally been known to to apoptosis by blocking the of repair to the DNA breaks during the course of apoptosis. The roles of the C-terminal fragment of PARP on apoptosis have not yet been The present that the association of the cellular PARP with the C-terminal fragment containing the auto-modification domain to apoptosis by blocking the homodimerization of PARP in cells irradiated with The C-terminal fragments of PARP containing the auto-modification domain interacted with intact PARP, whereas the N-terminal fragment containing the DNA-binding domain interacted with The association between the N-terminal fragment and intact PARP DNase I that the association was by DNA We further that the motif in the auto-modification domain is the site of of the cellular PARP 2 The homodimerization of PARP was by the expression of PARP cleavage products containing the motif in HeLa cells 2 The Leu405 in the motif was of critical importance in the required for the association and an of PARP The association of PARP with the basic of the auto-modification domain in the C-terminal fragment to with the homodimerization of PARP. are of studies that as an biochemical for the of protein was known to for the of catalytic activity of B.M. 1991; PubMed Scopus Google Scholar, K.J. S. D.J. J. Biol. Chem. 1993; Full Text PDF PubMed Google Scholar) and receptor J. 1998; PubMed Scopus Google Scholar, Cell. 1995; 80: Full Text PDF PubMed Scopus Google Scholar). studies have for the inhibition of protein by the from the For example, the catalytic activity of E. was shown to be by the C-terminal inhibits the homodimerization of the B.M. 1991; PubMed Scopus Google Scholar). The truncated G protein-coupled the of of were as of function J. 1998; PubMed Scopus Google Scholar). was known that the catalytic function of PARP is PARP to be to the A. E. Biochem. J. PubMed Scopus Google Scholar, H. R. J. Biol. Chem. 1993; Full Text PDF PubMed Google Scholar). in 4 that the expression of the C-terminal fragment of PARP in UV-treated HeLa cells suppresses auto-poly(ADP-ribosyl)ation of PARP, by blocking the homodimerization of the cellular PARP. The of the homodimerization may with the binding of PARP to DNA breaks, resulting in the catalytic of PARP. However, the expression of a PARP fragment that the C-terminal fragment but the auto-modification domain the cellular PARP activity. The inhibition of PARP activity by the N-terminal fragment might be the with the cellular PARP activity was by the expression of the N-terminal fragment of PARP. is to the that the N-terminal fragment of PARP with intact PARP for binding at DNA breaks, PARP The pro-apoptotic role of the C-terminal fragment of PARP on apoptosis was in annexin-V binding and caspase activation are well of apoptosis T. E. J. Cell Biol. 1997; PubMed Scopus Google Scholar). results suggest that the pro-apoptotic role of the C-terminal fragment of PARP not with the caspase activation in cells undergoing UV-mediated apoptosis. The level of caspase activity in cells expressing the C-terminal fragment that the motif was as in cells expressing PARP cleavage products containing the However, the intracellular caspase activity was by the expression of a known inhibitor of M. K. Desnoyers S. Poirier G.G. Cell. 1995; Full Text PDF PubMed Scopus Google Scholar). However, the expression of the C-terminal fragment of PARP stimulated UV-mediated apoptosis as assessed by the of annexin-V positive cells 5 In the expression of PARP fragments containing the motif and stimulated the induction of to apoptosis in UV-treated HeLa cells 5 These results suggest that the association of PARP at the motif is required for the completion of apoptosis. The homodimerization of PARP might the of apoptotic cell the caspase activation
36
Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE
Yuri Lazebnik, Scott H. Kaufmann, Serge Desnoyers et al. · Nature · 1994 · 2.6K citations
A short amino acid sequence able to specify nuclear location
Daniel Kalderon, Bruce Roberts, William D. Richardson et al. · Cell · 1984 · 2.6K citations
Gerrit Koopman, CP Reutelingsperger, GA Kuijten et al. · Blood · 1994 · 2.5K citations · Full text
Medicine, Cell Biology, Pathology +11
Gerrit Koopman, CP Reutelingsperger, GA Kuijten et al. · Blood · 1994 · 2.1K citations
Medicine, Cell Biology, Pathology +11